Age-Related Effect of Uric Acid on Contrast-Induced Acute Kidney Injury of Patients Undergoing Coronary Angiography

Jin Lu1, Yibo He2,3, Yanfang Yang1

  • 1Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, People's Republic of China.

PubMed

Insights

Age significantly influences the link between uric acid and contrast-induced acute kidney injury (CI-AKI). Optimal uric acid levels for reducing CI-AKI risk differ across age groups, with younger individuals showing no significant association.

Area of Science:

  • Nephrology
  • Cardiology
  • Biochemistry

Background:

  • Established association between uric acid (UA) and contrast-induced acute kidney injury (CI-AKI) after coronary angiography (CAG).
  • The influence of age on the UA-CI-AKI relationship remained unclear.

Purpose of the Study:

  • To investigate how age modifies the association between uric acid levels and the risk of CI-AKI following coronary angiography.
  • To determine age-specific uric acid thresholds for CI-AKI risk stratification.

Main Methods:

  • Retrospective analysis of 36,550 patients from the Cardio-renal Improvement II study (NCT05050877).
  • CI-AKI defined as serum creatinine rise ≥ 0.5 mg/dL or 25% within 48 hours post-CAG.
  • Logistic regression and restricted cubic splines used to assess age-dependent UA-CI-AKI associations.

Main Results:

  • In young patients, UA levels showed an insignificant association with CI-AKI risk.
  • Middle-aged patients: lower UA linked to lower CI-AKI risk; higher UA linked to higher risk (Q4 OR: 1.797).
  • Elderly patients: both low and high UA levels were associated with increased CI-AKI risk (Q1 OR: 1.247, Q4 OR: 1.688).
  • Non-linear UA-CI-AKI association observed in middle and elder groups; linear in the young group.

Conclusions:

  • The association between uric acid and CI-AKI risk is age-dependent.
  • Elderly patients benefit from maintaining mid-range UA levels; middle-aged patients from lower UA levels.
  • Uric acid is not a significant risk factor for CI-AKI in young patients.
Abstract

Related Concept Videos

Radiological Investigation I: X-ray and CT01:30

Radiological Investigation I: X-ray and CT

Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
244
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
98
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436